BlackRock Investment Management’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$91.1M Buy
760,581
+41,075
+6% +$4.73M 0.11% 193
2016
Q3
$83.8M Sell
719,506
-6,966
-1% -$812K 0.1% 200
2016
Q2
$87.1M Buy
726,472
+55,268
+8% +$6.18M 0.11% 191
2016
Q1
$72M Sell
671,204
-15,215
-2% -$1.5M 0.09% 208
2015
Q4
$63.8M Sell
686,419
-43,004
-6% -$4.12M 0.08% 227
2015
Q3
$68.6M Buy
729,423
+43,708
+6% +$4.33M 0.09% 212
2015
Q2
$65.5M Buy
685,715
+56,576
+9% +$5.36M 0.08% 230
2015
Q1
$58M Buy
629,139
+6,027
+1% +$561K 0.08% 257
2014
Q4
$58.8M Buy
623,112
+12,969
+2% +$1.15M 0.08% 257
2014
Q3
$49.3M Sell
610,143
-1,140
-0.2% -$93.8K 0.07% 275
2014
Q2
$51.5M Buy
611,283
+95,756
+19% +$7.82M 0.07% 281
2014
Q1
$42M Buy
515,527
+14,962
+3% +$1.19M 0.06% 295
2013
Q4
$37.6M Sell
500,565
-19,630
-4% -$1.43M 0.06% 312
2013
Q3
$35.2M Buy
520,195
+30,625
+6% +$2.11M 0.06% 302
2013
Q2
$31.7M Buy
+489,570
New +$32.5M 0.06% 306

Other funds holding SYK

BlackRock Investment Management's SYK Position: Q4 2016 in Review

BlackRock Investment Management increased its Stryker (SYK) stake by 5.7% in Q4 2016, buying an estimated $4.73M and bringing the position to 760,581 shares worth $91.1M. The position accounts for 0.11% of the portfolio, ranked #193.

BlackRock Investment Management first reported a position in SYK in Q2 2013 and has held it in 15 quarters since. 985 funds tracked by Wall St. Rank hold SYK as of Q4 2016.

  • BlackRock Investment Management held 760,581 shares of Stryker worth $91.1M as of Q4 2016.
  • BlackRock Investment Management bought 41,075 Stryker shares in Q4 2016, an estimated $4.73M.
  • Stryker made up 0.11% of BlackRock Investment Management's portfolio in Q4 2016, its #193 holding.
  • BlackRock Investment Management first reported a position in Stryker in Q2 2013 and has held it in 15 quarters since.
  • 985 funds tracked by Wall St. Rank held Stryker as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.